Novel Anticancer Drug Yields Positive Response in People with Advanced Or Recurring Skin and Brain Cancer

The Hedgehog signaling pathway is involved in a preliminary study and case report describing positive responses to an experimental anticancer drug in a majority of people with advanced or metastatic basal cell skin cancers. One patient with the most common type of pediatric brain cancer, medulloblastoma, also showed tumor shrinkage.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews